Cancer Chemotherapy And Pharmacology

Clinically relevant concentrations of lidocaine inhibit tumor angiogenesis through suppressing VEGF/VEGFR2 signaling

Comparative assessment of pharmacokinetics, and pharmacodynamics between RTXM83 (TM), a rituximab biosimilar, and rituximab in diffuse large B-cell lymphoma patients: a population PK model approach

Role of TPMT and ITPA variants in mercaptopurine disposition

Alternative dosing regimens for atezolizumab: right dose, wrong frequency

Targeted disruption of PI3K/Akt/mTOR signaling pathway, via PI3K inhibitors, promotes growth inhibitory effects in oral cancer cells

Expression of M2 macrophage markers YKL-39 and CCL18 in breast cancer is associated with the effect of neoadjuvant chemotherapy

Exposure-response analysis of alectinib in crizotinib-resistant ALK-positive non-small cell lung cancer

Resistance mechanisms and potent-targeted therapies of ROS1-positive lung cancer

MircroRNA-139 sensitizes ovarian cancer cell to cisplatin-based chemotherapy through regulation of ATP7A/B

Nab-paclitaxel plus S-1 as first-line followed by S-1 maintenance for advanced pancreatic adenocarcinoma: a single-arm phase II trial